Japanische Zeitschrift f. Dermat. u. Urologie

Pick, Walther

doi:10.1007/bf01838623

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There are three main strategies that have emerged to engineer the hybrid EVs: freeze‐thaw cycling, fusion‐incubation, and sonication [130] . Freeze‐thaw cycling is commonly used in the preparation of LSs to enhance their encapsulation efficiency [131,132] . This procedure has also been applied to generate hybrid EVs.…”

Section: Engineering Hybrid Delivery Systemmentioning

confidence: 99%

Current advances in non‐viral gene delivery systems: Liposomes versus extracellular vesicles

Belhadj

Qie

Carney

et al. 2023

BMEMat

View full text Add to dashboard Cite

In the past decade, nucleic acid-based drugs have emerged as an extremely promising approach for silencing specific disease-related genes and targeting undruggable ones. However, most nucleic acid drug therapies have not advanced to clinical practice due to their poor stability against serum enzyme degradation and cytotoxicity. Nanoscale drug delivery vehicles show potential to improve efficacy of nucleic acid drugs via targeted delivery to diseasecausing genes, yet, safe and efficient nanocarriers remain elusive. Lipidbased nanoparticles such as liposomes (LSs) and extracellular vesicles (EVs) are among the most extensively exploited nanoscale vehicles for therapeutic cargo delivery. LS-based nucleic acid therapies have been used for several years, with many already adopted to the clinic. More recently, EVs hold considerable promise as nucleic acid delivery vehicles due to their high biocompatibility, low immunogenicity, and the inherent abilities to interact with target cells and cross biological barriers. Moreover, a novel LS/EV hybrid gene delivery system has been engineered to preserve the benefits of both systems and generate an advanced drug delivery system. The current review focuses specifically on LS-and EV-based gene therapies and provides the key advantages and shortcomings of these systems with particular emphasis on their potential use as therapeutic vectors.Zakia Belhadj and Yunkai Qie contributed equally to this work.This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

show abstract

Section: Engineering Hybrid Delivery Systemmentioning

confidence: 99%